{
    "2020-01-03": [
        [
            {
                "time": "2020-01-01",
                "original_text": "Novartis, Merck and Allergan join those raising U.S. drug prices for 2020",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Merck",
                        "Allergan",
                        "U.S. drug prices",
                        "raising"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-01-01",
                "original_text": "Incyte's (INCY) Itacitinib Fails in Late-Stage GVHD Study",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Itacitinib",
                        "Fails",
                        "Late-Stage",
                        "GVHD",
                        "Study"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-01-01",
                "original_text": "Glaxo (GSK) Shares Continue to Witness Upside: Here's Why",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Shares",
                        "Upside"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}